Design, Synthesis and Antitumor Activity of FAK/PLK1 Dual Inhibitors with Quinazolinone as the Skeleton
Chemistry & Biodiversity · 2023
DOI: 10.1002/cbdv.202300146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2023. Verfasst von Juan Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological & Chemical Engineering, Zhejiang University of Science & Technology, Hangzhou, 310023, P. R. China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Protein Kinase Inhibitors, Quinazolinones. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Ningbo.
Abstract (Originalsprache)
Febrifugine is a kind of quinazolinone compound with high biological activity from a Chinese herb called Chang Shan ( Dichroa febrifuga ). Febrifugine and its derivatives possess extensive biological activities, some of which exhibited anti‐tumor activities as FAK inhibitors. However, they are not very effective at inhibiting tumor metastasis, perhaps because tumors gain energy through compensatory activation of other signaling pathways that promote cell migration and invasion. Therefore, seventeen novel febrifugine derivatives with quinazolinone skeleton were designed, synthesized and acted as potential FAK/PLK1 dual inhibitors. These compounds were determined by 1 H‐NMR, 13 C‐NMR and MS. Most of the compounds exhibited good inhibitory activity against cancer cell lines by computer‐assisted screening, antitumor activity test and FAK/PLK1 inhibitory activity test, wherein compound 3b was screened as a high‐efficiency lead compound.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological & Chemical Engineering, Zhejiang University of Science & Technology, Hangzhou, 310023, P. R. China.
- Zhejiang Engineering Research Center for Biomedical Materials, Cixi Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315300, P. R. China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Ningbo
Zitieren
APA
Sun, J., Fang, Z. Y., Tao, Y. N., Zhang, Y. H., Zhang, Y., Sun, H. Y., Zhou, Y., & Wu, Y. F. (2023). Design, Synthesis and Antitumor Activity of FAK/PLK1 Dual Inhibitors with Quinazolinone as the Skeleton. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202300146
Vancouver
Sun J, Fang ZY, Tao YN, Zhang YH, Zhang Y, Sun HY, et al. Design, Synthesis and Antitumor Activity of FAK/PLK1 Dual Inhibitors with Quinazolinone as the Skeleton. Chemistry & Biodiversity. 2023. doi:10.1002/cbdv.202300146
BibTeX
@article{Sun2023,
author = {Sun, Juan and Fang, Ze-Yu and Tao, Yi-Nuo and Zhang, Yi-Heng and Zhang, Yao and Sun, Hai-Ya and Zhou, Yang and Wu, Yuan-Feng},
title = {Design, Synthesis and Antitumor Activity of FAK/PLK1 Dual Inhibitors with Quinazolinone as the Skeleton},
journal = {Chemistry & Biodiversity},
year = {2023},
doi = {10.1002/cbdv.202300146}
}
EUVIMED